nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ADRA1B—vas deferens—testicular cancer	0.182	0.783	CbGeAlD
Terazosin—ABCB1—Dactinomycin—testicular cancer	0.0588	0.284	CbGbCtD
Terazosin—ABCB1—Vinblastine—testicular cancer	0.0368	0.178	CbGbCtD
Terazosin—ABCB1—Cisplatin—testicular cancer	0.0338	0.163	CbGbCtD
Terazosin—ABCB1—Etoposide—testicular cancer	0.0332	0.16	CbGbCtD
Terazosin—ABCB1—Doxorubicin—testicular cancer	0.0226	0.109	CbGbCtD
Terazosin—ABCB1—Methotrexate—testicular cancer	0.0219	0.106	CbGbCtD
Terazosin—KCNH7—testis—testicular cancer	0.0178	0.0764	CbGeAlD
Terazosin—KCNH2—seminal vesicle—testicular cancer	0.00748	0.0321	CbGeAlD
Terazosin—KCNH2—female gonad—testicular cancer	0.00439	0.0189	CbGeAlD
Terazosin—KCNH2—testis—testicular cancer	0.00389	0.0167	CbGeAlD
Terazosin—ABCB1—embryo—testicular cancer	0.00349	0.015	CbGeAlD
Terazosin—ABCB1—seminal vesicle—testicular cancer	0.00328	0.0141	CbGeAlD
Terazosin—KCNH2—lymph node—testicular cancer	0.00282	0.0121	CbGeAlD
Terazosin—ABCB1—gonad—testicular cancer	0.00237	0.0102	CbGeAlD
Terazosin—ABCB1—female gonad—testicular cancer	0.00193	0.00827	CbGeAlD
Terazosin—ABCB1—testis—testicular cancer	0.00171	0.00734	CbGeAlD
Terazosin—ABCB1—lymph node—testicular cancer	0.00124	0.00532	CbGeAlD
Terazosin—Anorexia—Etoposide—testicular cancer	0.000995	0.00178	CcSEcCtD
Terazosin—Decreased appetite—Cisplatin—testicular cancer	0.00099	0.00177	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—testicular cancer	0.000989	0.00177	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—testicular cancer	0.000986	0.00176	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000985	0.00176	CcSEcCtD
Terazosin—Vomiting—Bleomycin—testicular cancer	0.000983	0.00175	CcSEcCtD
Terazosin—Depression—Methotrexate—testicular cancer	0.000977	0.00174	CcSEcCtD
Terazosin—Hypotension—Etoposide—testicular cancer	0.000975	0.00174	CcSEcCtD
Terazosin—Rash—Bleomycin—testicular cancer	0.000975	0.00174	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—testicular cancer	0.000974	0.00174	CcSEcCtD
Terazosin—Pain—Cisplatin—testicular cancer	0.000974	0.00174	CcSEcCtD
Terazosin—Dermatitis—Bleomycin—testicular cancer	0.000974	0.00174	CcSEcCtD
Terazosin—Hypersensitivity—Ifosfamide—testicular cancer	0.000973	0.00174	CcSEcCtD
Terazosin—Dysuria—Epirubicin—testicular cancer	0.000962	0.00172	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—testicular cancer	0.000952	0.0017	CcSEcCtD
Terazosin—Asthma—Doxorubicin—testicular cancer	0.000952	0.0017	CcSEcCtD
Terazosin—Influenza—Doxorubicin—testicular cancer	0.000952	0.0017	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—testicular cancer	0.00095	0.0017	CcSEcCtD
Terazosin—Asthenia—Ifosfamide—testicular cancer	0.000948	0.00169	CcSEcCtD
Terazosin—Sweating—Methotrexate—testicular cancer	0.000939	0.00168	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000939	0.00168	CcSEcCtD
Terazosin—Feeling abnormal—Cisplatin—testicular cancer	0.000939	0.00168	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—testicular cancer	0.000937	0.00167	CcSEcCtD
Terazosin—Weight increased—Epirubicin—testicular cancer	0.000936	0.00167	CcSEcCtD
Terazosin—Pruritus—Ifosfamide—testicular cancer	0.000935	0.00167	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—testicular cancer	0.00093	0.00166	CcSEcCtD
Terazosin—Somnolence—Etoposide—testicular cancer	0.000928	0.00166	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—testicular cancer	0.000927	0.00165	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—testicular cancer	0.000924	0.00165	CcSEcCtD
Terazosin—Nausea—Bleomycin—testicular cancer	0.000918	0.00164	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—testicular cancer	0.000917	0.00164	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—testicular cancer	0.000915	0.00163	CcSEcCtD
Terazosin—Rash—Dactinomycin—testicular cancer	0.000909	0.00162	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—testicular cancer	0.000907	0.00162	CcSEcCtD
Terazosin—Diarrhoea—Ifosfamide—testicular cancer	0.000904	0.00161	CcSEcCtD
Terazosin—Body temperature increased—Cisplatin—testicular cancer	0.0009	0.00161	CcSEcCtD
Terazosin—Fatigue—Etoposide—testicular cancer	0.0009	0.00161	CcSEcCtD
Terazosin—Jaundice—Epirubicin—testicular cancer	0.000894	0.0016	CcSEcCtD
Terazosin—Constipation—Etoposide—testicular cancer	0.000892	0.00159	CcSEcCtD
Terazosin—Pain—Etoposide—testicular cancer	0.000892	0.00159	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—testicular cancer	0.000891	0.00159	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—testicular cancer	0.000891	0.00159	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—testicular cancer	0.00089	0.00159	CcSEcCtD
Terazosin—Sweating—Epirubicin—testicular cancer	0.000879	0.00157	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—testicular cancer	0.000879	0.00157	CcSEcCtD
Terazosin—Dizziness—Ifosfamide—testicular cancer	0.000874	0.00156	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—testicular cancer	0.000873	0.00156	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000869	0.00155	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—testicular cancer	0.000866	0.00155	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—testicular cancer	0.000865	0.00154	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—testicular cancer	0.00086	0.00154	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—testicular cancer	0.00086	0.00153	CcSEcCtD
Terazosin—Nausea—Dactinomycin—testicular cancer	0.000856	0.00153	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—testicular cancer	0.000853	0.00152	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—testicular cancer	0.000848	0.00151	CcSEcCtD
Terazosin—Vomiting—Ifosfamide—testicular cancer	0.00084	0.0015	CcSEcCtD
Terazosin—Hypersensitivity—Cisplatin—testicular cancer	0.000839	0.0015	CcSEcCtD
Terazosin—Rash—Ifosfamide—testicular cancer	0.000833	0.00149	CcSEcCtD
Terazosin—Dermatitis—Ifosfamide—testicular cancer	0.000832	0.00149	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—testicular cancer	0.000827	0.00148	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—testicular cancer	0.000825	0.00147	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—testicular cancer	0.000825	0.00147	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—testicular cancer	0.000825	0.00147	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—testicular cancer	0.000825	0.00147	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—testicular cancer	0.000825	0.00147	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—testicular cancer	0.000822	0.00147	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—testicular cancer	0.00082	0.00146	CcSEcCtD
Terazosin—Asthenia—Cisplatin—testicular cancer	0.000817	0.00146	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—testicular cancer	0.000817	0.00146	CcSEcCtD
Terazosin—Sweating—Doxorubicin—testicular cancer	0.000813	0.00145	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—testicular cancer	0.000811	0.00145	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—testicular cancer	0.0008	0.00143	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—testicular cancer	0.000796	0.00142	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—testicular cancer	0.000793	0.00142	CcSEcCtD
Terazosin—Nausea—Ifosfamide—testicular cancer	0.000785	0.0014	CcSEcCtD
Terazosin—Diarrhoea—Cisplatin—testicular cancer	0.000779	0.00139	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—testicular cancer	0.000769	0.00137	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—testicular cancer	0.000769	0.00137	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—testicular cancer	0.000768	0.00137	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—testicular cancer	0.000766	0.00137	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—testicular cancer	0.000764	0.00136	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—testicular cancer	0.000756	0.00135	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—testicular cancer	0.00075	0.00134	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—testicular cancer	0.00075	0.00134	CcSEcCtD
Terazosin—Asthenia—Etoposide—testicular cancer	0.000749	0.00134	CcSEcCtD
Terazosin—Back pain—Methotrexate—testicular cancer	0.000741	0.00132	CcSEcCtD
Terazosin—Pruritus—Etoposide—testicular cancer	0.000738	0.00132	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—testicular cancer	0.000735	0.00131	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—testicular cancer	0.000734	0.00131	CcSEcCtD
Terazosin—Vomiting—Cisplatin—testicular cancer	0.000724	0.00129	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—testicular cancer	0.000722	0.00129	CcSEcCtD
Terazosin—Rash—Cisplatin—testicular cancer	0.000718	0.00128	CcSEcCtD
Terazosin—Dermatitis—Cisplatin—testicular cancer	0.000717	0.00128	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—testicular cancer	0.000717	0.00128	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—testicular cancer	0.000714	0.00127	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—testicular cancer	0.000712	0.00127	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—testicular cancer	0.00071	0.00127	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—testicular cancer	0.00071	0.00127	CcSEcCtD
Terazosin—Flatulence—Epirubicin—testicular cancer	0.000706	0.00126	CcSEcCtD
Terazosin—Tension—Epirubicin—testicular cancer	0.000703	0.00126	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—testicular cancer	0.000702	0.00125	CcSEcCtD
Terazosin—Nervousness—Epirubicin—testicular cancer	0.000696	0.00124	CcSEcCtD
Terazosin—Back pain—Epirubicin—testicular cancer	0.000693	0.00124	CcSEcCtD
Terazosin—Malaise—Methotrexate—testicular cancer	0.000691	0.00123	CcSEcCtD
Terazosin—Dizziness—Etoposide—testicular cancer	0.00069	0.00123	CcSEcCtD
Terazosin—Vertigo—Methotrexate—testicular cancer	0.000688	0.00123	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—testicular cancer	0.00068	0.00121	CcSEcCtD
Terazosin—Nausea—Cisplatin—testicular cancer	0.000676	0.00121	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—testicular cancer	0.000675	0.00121	CcSEcCtD
Terazosin—Cough—Methotrexate—testicular cancer	0.000668	0.00119	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—testicular cancer	0.000665	0.00119	CcSEcCtD
Terazosin—Convulsion—Methotrexate—testicular cancer	0.000663	0.00118	CcSEcCtD
Terazosin—Vomiting—Etoposide—testicular cancer	0.000663	0.00118	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—testicular cancer	0.000663	0.00118	CcSEcCtD
Terazosin—Rash—Etoposide—testicular cancer	0.000658	0.00117	CcSEcCtD
Terazosin—Dermatitis—Etoposide—testicular cancer	0.000657	0.00117	CcSEcCtD
Terazosin—Headache—Etoposide—testicular cancer	0.000654	0.00117	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—testicular cancer	0.000653	0.00117	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—testicular cancer	0.000652	0.00116	CcSEcCtD
Terazosin—Myalgia—Methotrexate—testicular cancer	0.000652	0.00116	CcSEcCtD
Terazosin—Chest pain—Methotrexate—testicular cancer	0.000652	0.00116	CcSEcCtD
Terazosin—Tension—Doxorubicin—testicular cancer	0.000651	0.00116	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—testicular cancer	0.000649	0.00116	CcSEcCtD
Terazosin—Malaise—Epirubicin—testicular cancer	0.000646	0.00115	CcSEcCtD
Terazosin—Discomfort—Methotrexate—testicular cancer	0.000644	0.00115	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—testicular cancer	0.000644	0.00115	CcSEcCtD
Terazosin—Vertigo—Epirubicin—testicular cancer	0.000644	0.00115	CcSEcCtD
Terazosin—Syncope—Epirubicin—testicular cancer	0.000643	0.00115	CcSEcCtD
Terazosin—Back pain—Doxorubicin—testicular cancer	0.000641	0.00115	CcSEcCtD
Terazosin—Palpitations—Epirubicin—testicular cancer	0.000633	0.00113	CcSEcCtD
Terazosin—Confusional state—Methotrexate—testicular cancer	0.00063	0.00112	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—testicular cancer	0.00063	0.00112	CcSEcCtD
Terazosin—Cough—Epirubicin—testicular cancer	0.000625	0.00112	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—testicular cancer	0.000625	0.00112	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—testicular cancer	0.000625	0.00112	CcSEcCtD
Terazosin—Convulsion—Epirubicin—testicular cancer	0.000621	0.00111	CcSEcCtD
Terazosin—Nausea—Etoposide—testicular cancer	0.00062	0.00111	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000615	0.0011	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—testicular cancer	0.000612	0.00109	CcSEcCtD
Terazosin—Myalgia—Epirubicin—testicular cancer	0.00061	0.00109	CcSEcCtD
Terazosin—Chest pain—Epirubicin—testicular cancer	0.00061	0.00109	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—testicular cancer	0.00061	0.00109	CcSEcCtD
Terazosin—Anxiety—Epirubicin—testicular cancer	0.000608	0.00109	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—testicular cancer	0.000604	0.00108	CcSEcCtD
Terazosin—Discomfort—Epirubicin—testicular cancer	0.000603	0.00108	CcSEcCtD
Terazosin—Malaise—Doxorubicin—testicular cancer	0.000598	0.00107	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—testicular cancer	0.000597	0.00107	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—testicular cancer	0.000596	0.00106	CcSEcCtD
Terazosin—Anorexia—Methotrexate—testicular cancer	0.000596	0.00106	CcSEcCtD
Terazosin—Syncope—Doxorubicin—testicular cancer	0.000595	0.00106	CcSEcCtD
Terazosin—Confusional state—Epirubicin—testicular cancer	0.00059	0.00105	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—testicular cancer	0.000586	0.00105	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—testicular cancer	0.000585	0.00104	CcSEcCtD
Terazosin—Oedema—Epirubicin—testicular cancer	0.000585	0.00104	CcSEcCtD
Terazosin—Hypotension—Methotrexate—testicular cancer	0.000584	0.00104	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—testicular cancer	0.000583	0.00104	CcSEcCtD
Terazosin—Cough—Doxorubicin—testicular cancer	0.000579	0.00103	CcSEcCtD
Terazosin—Shock—Epirubicin—testicular cancer	0.000575	0.00103	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—testicular cancer	0.000575	0.00103	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—testicular cancer	0.000573	0.00102	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—testicular cancer	0.000571	0.00102	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000569	0.00102	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—testicular cancer	0.000565	0.00101	CcSEcCtD
Terazosin—Insomnia—Methotrexate—testicular cancer	0.000565	0.00101	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—testicular cancer	0.000565	0.00101	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—testicular cancer	0.000565	0.00101	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—testicular cancer	0.000565	0.00101	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—testicular cancer	0.000563	0.001	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—testicular cancer	0.000561	0.001	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—testicular cancer	0.000558	0.000996	CcSEcCtD
Terazosin—Anorexia—Epirubicin—testicular cancer	0.000557	0.000995	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—testicular cancer	0.000557	0.000995	CcSEcCtD
Terazosin—Somnolence—Methotrexate—testicular cancer	0.000556	0.000992	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—testicular cancer	0.000552	0.000986	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—testicular cancer	0.00055	0.000982	CcSEcCtD
Terazosin—Hypotension—Epirubicin—testicular cancer	0.000547	0.000976	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—testicular cancer	0.000546	0.000974	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—testicular cancer	0.000543	0.00097	CcSEcCtD
Terazosin—Oedema—Doxorubicin—testicular cancer	0.000541	0.000966	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000541	0.000966	CcSEcCtD
Terazosin—Fatigue—Methotrexate—testicular cancer	0.000539	0.000962	CcSEcCtD
Terazosin—Pain—Methotrexate—testicular cancer	0.000534	0.000954	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000533	0.000951	CcSEcCtD
Terazosin—Shock—Doxorubicin—testicular cancer	0.000532	0.00095	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—testicular cancer	0.00053	0.000946	CcSEcCtD
Terazosin—Insomnia—Epirubicin—testicular cancer	0.000529	0.000944	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—testicular cancer	0.000528	0.000943	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—testicular cancer	0.000525	0.000938	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000523	0.000934	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—testicular cancer	0.000521	0.000931	CcSEcCtD
Terazosin—Somnolence—Epirubicin—testicular cancer	0.00052	0.000928	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—testicular cancer	0.000516	0.000921	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—testicular cancer	0.000515	0.000919	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—testicular cancer	0.000515	0.000919	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000511	0.000912	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—testicular cancer	0.000508	0.000908	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—testicular cancer	0.000506	0.000903	CcSEcCtD
Terazosin—Fatigue—Epirubicin—testicular cancer	0.000504	0.0009	CcSEcCtD
Terazosin—Pain—Epirubicin—testicular cancer	0.0005	0.000893	CcSEcCtD
Terazosin—Constipation—Epirubicin—testicular cancer	0.0005	0.000893	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—testicular cancer	0.000494	0.000882	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—testicular cancer	0.000494	0.000882	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000493	0.00088	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—testicular cancer	0.000489	0.000874	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—testicular cancer	0.000486	0.000868	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—testicular cancer	0.000482	0.000861	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—testicular cancer	0.000482	0.00086	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—testicular cancer	0.000481	0.000859	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000478	0.000854	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—testicular cancer	0.000476	0.00085	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—testicular cancer	0.00047	0.00084	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—testicular cancer	0.000467	0.000833	CcSEcCtD
Terazosin—Constipation—Doxorubicin—testicular cancer	0.000463	0.000826	CcSEcCtD
Terazosin—Pain—Doxorubicin—testicular cancer	0.000463	0.000826	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—testicular cancer	0.000462	0.000825	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—testicular cancer	0.000462	0.000825	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—testicular cancer	0.00046	0.000822	CcSEcCtD
Terazosin—Asthenia—Methotrexate—testicular cancer	0.000448	0.000801	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—testicular cancer	0.000446	0.000796	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000443	0.00079	CcSEcCtD
Terazosin—Pruritus—Methotrexate—testicular cancer	0.000442	0.000789	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—testicular cancer	0.000431	0.000769	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—testicular cancer	0.000428	0.000764	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—testicular cancer	0.000428	0.000764	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—testicular cancer	0.000428	0.000763	CcSEcCtD
Terazosin—Asthenia—Epirubicin—testicular cancer	0.00042	0.000749	CcSEcCtD
Terazosin—Pruritus—Epirubicin—testicular cancer	0.000414	0.000739	CcSEcCtD
Terazosin—Dizziness—Methotrexate—testicular cancer	0.000413	0.000738	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—testicular cancer	0.0004	0.000714	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—testicular cancer	0.000399	0.000712	CcSEcCtD
Terazosin—Vomiting—Methotrexate—testicular cancer	0.000397	0.000709	CcSEcCtD
Terazosin—Rash—Methotrexate—testicular cancer	0.000394	0.000703	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—testicular cancer	0.000394	0.000703	CcSEcCtD
Terazosin—Headache—Methotrexate—testicular cancer	0.000392	0.000699	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—testicular cancer	0.000388	0.000693	CcSEcCtD
Terazosin—Dizziness—Epirubicin—testicular cancer	0.000387	0.00069	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—testicular cancer	0.000383	0.000684	CcSEcCtD
Terazosin—Vomiting—Epirubicin—testicular cancer	0.000372	0.000664	CcSEcCtD
Terazosin—Nausea—Methotrexate—testicular cancer	0.000371	0.000663	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—testicular cancer	0.00037	0.000661	CcSEcCtD
Terazosin—Rash—Epirubicin—testicular cancer	0.000369	0.000658	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—testicular cancer	0.000368	0.000658	CcSEcCtD
Terazosin—Headache—Epirubicin—testicular cancer	0.000366	0.000654	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—testicular cancer	0.000358	0.000639	CcSEcCtD
Terazosin—Nausea—Epirubicin—testicular cancer	0.000347	0.00062	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—testicular cancer	0.000344	0.000614	CcSEcCtD
Terazosin—Rash—Doxorubicin—testicular cancer	0.000341	0.000609	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—testicular cancer	0.000341	0.000609	CcSEcCtD
Terazosin—Headache—Doxorubicin—testicular cancer	0.000339	0.000605	CcSEcCtD
Terazosin—Nausea—Doxorubicin—testicular cancer	0.000321	0.000574	CcSEcCtD
